基于网络药理学的扶正调理液作用机制及其对S180荷瘤小鼠的影响

doi:10.3976/j.issn.1002-4026.2022.01.007

Abstract

Abstract:

This study aimed to discover the molecular mechanism of Fuzheng Tiaoli Decoction based on network pharmacology. The Bioinformatics Analysis Tool of Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM) server was used to predict the potential targets of Fuzheng Tiaoli Decoction and construct a compound-target-pathway-disease interaction network diagram. The protein-protein interaction network of key targets was built using the STRING database based on gene ontology (GO), Reactome, and Kyoto encyclopedia of genes and genomes (KEGG) database for biological pathway enrichment analysis. Furthermore, the effect of Fuzheng Tiaoli Decoction on the body weight and eating habit of S180 tumor-bearing mice was studied, and the tumor inhibition rate and thymus and spleen indices were calculated. The results showed that the target network of Fuzheng Tiaoli decoction mainly involves cancer (nonspecific), analgesia, breast cancer, cardiovascular disease, inflammation, prostate cancer, depression, and other diseases and key targets such as OPRK1, NR3C1, NR3C2, ADORA1, ESR1, etc. GO enrichment analysis involved cytosol, cytoplasmic membrane, oxidoreductase activity, transmembrane transport protein activity, cellular amino acid, and other small molecule metabolism processes. Reactome pathway enrichment analysis involved neuronal systems, cross-chemical synapses transmission, neurotransmitter receptors, and post-synaptic signal transmission. KEGG pathway enrichment analysis involved neural activity ligand-receptor interactions, calcium signaling pathways, serotonergic synapses, taste transduction, amino acid metabolism, saliva secretion, etc. Animal experiment results showed that the food intake, mental state, and coat gloss of mice in the low-dose and high-dose groups were better than those in the positive and negative groups. The 28-day body mass growth rate of high-dose groups is higher significant than others, respectively; the tumor suppression rates of the low-dose, high-dose, and positive groups were 8.73%, 19.54%, and 47.89%, respectively.The thymus index of low-dose and high-dose groups is lower than positive group but higher than negative groups significant;the spleen index of high-dose group is lower than positive group significant.This study suggests that Fuzheng Tiaoli Decoction may mediate neural activity ligand-receptor interactions, calcium signaling pathways, serotonergic synapses, taste transduction, amino acid metabolism, salivary secretion, and other signaling pathways by affecting the expression of key target genes and improves anxiety, depression, and other negative mental states. Furthermore, it improves sleep quality, reduces fatigue, improves appetite and nutritional status, enhances immune function, improves the state of splenomegaly and thymus atrophy, enhances the immune function and inhibits tumor progression in tumor-bearing mice. The multi-target characteristics and integral action of Traditional Chinese Medicine compounds provide novel ideas for further research on the molecular mechanism of Fuzheng Tiaoli Decoction.

Key words: Fuzheng Tiaoli Decoction, anti-tumor, immunity, sub-health, network pharmacology

CLC Number:

R285.5

CAO Ming-chen,PENG Xiao-ju,HUANG Xian-ju,KE Cai-hua,WANG Chuan,XIN Zhao-yang,YU Zhen-ying,PAN Dong-qi,CUI Meng-na. Mechanism of Fuzheng Tiaoli Decoction based on network pharmacology and its effect on S180 tumor-bearing mice[J].Shandong Science, 2022, 35(1): 45-55.

Figures/Tables 9

Fig.1

Fig.2

Fig.3

Fig.4

Fig.5

Fig. 6

Fig.7

Fig.8

Fig. 9

References 35

[1]	刘曾晶, 张梦林, 康前前, 等. 基于数据挖掘的抗肿瘤中药方剂用药规律分析[J]. 亚太传统医药, 2020, 16(8):143-145. DOI: 10.11954/ytctyy.202008044. doi: 10.11954/ytctyy.202008044
[2]	彭小菊, 汪川, 于振英, 等. 分析中医调理和治疗亚健康的临床优势[J]. 智慧健康, 2018, 4(13):26-28. DOI: 10.19335/j.cnki.2096-1219.2018.13.012. doi: 10.19335/j.cnki.2096-1219.2018.13.012
[3]	彭小菊, 孙立波, 汪川, 等. 扶正调理口服液对化疗后白细胞及中性粒细胞的作用观察[J]. 山东医药, 2012, 52(15):74-75.
[4]	张宝月, 郑一夫, 庞晓丛, 等. 中药抗肿瘤作用的物质基础与网络机制研究[J]. 世界中医药, 2018, 13(8):1997-2009. DOI: 10.3969/j.issn.1673-7202.2018.08.044. doi: 10.3969/j.issn.1673-7202.2018.08.044
[5]	孙晓伟, 彭小菊, 孙向红. 增龄Ⅰ号治疗中老年冠心病心绞痛45例临床观察[J]. 湖南中医杂志, 2018, 34(5):3-4. DOI: 10.16808/j.cnki.issn1003-7705.2018.05.002. doi: 10.16808/j.cnki.issn1003-7705.2018.05.002
[6]	彭小菊, 韩嘉, 韩建国. 一种亚健康调理液及其制备方法:CN103989936A[P]. 2014-08-20.
[7]	许洪彬, 綦向军, 方彩珊, 等. 基于网络药理学及分子对接探讨穿心莲内酯抗肿瘤机制[J]. 中国医院药学杂志, 2020, 40(12):1312-1319. DOI: 10.13286/j.1001-5213.2020.12.07. doi: 10.13286/j.1001-5213.2020.12.07
[8]	刘莹, 张世超. 基于网络药理学的白花蛇舌草-半枝莲抗肿瘤作用机制研究[J]. 辽宁中医药大学学报, 2020, 22(8):27-31. DOI: 10.13194/j.issn.1673-842x.2020.08.008. doi: 10.13194/j.issn.1673-842x.2020.08.008
[9]	张磊, 程健, 余莹, 等. 活血祛瘀药对三棱-莪术治疗胃癌的网络药理学作用机制研究[J]. 浙江中医药大学学报, 2020, 44(8):773-782. DOI: 10.16466/j.issn1005-5509.2020.08.013. doi: 10.16466/j.issn1005-5509.2020.08.013
[10]	LIU Z Y, GUO F F, WANG Y, et al. BATMAN-TCM: a bioinformatics analysis tool for molecular mechANism of traditional Chinese medicine[J]. Scientific Reports, 2016, 6:21146. DOI: 10.1038/srep21146. doi: 10.1038/srep21146
[11]	SHANNON P, MARKIEL A, OZIER O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks[J]. Genome Research, 2003, 13(11):2498-2504. DOI: 10.1101/gr.1239303. doi: 10.1101/gr.1239303
[12]	HUANG D W, SHERMAN B T, LEMPICKI R A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources[J]. Nature Protocols, 2009, 4(1):44-57. DOI: 10.1038/nprot.2008.211. doi: 10.1038/nprot.2008.211
[13]	Kanehisa Laboratories. KEGG:Kyoto Encyclopedia of Genes and Genomes [EB/OL].[2021-01-23]. https://www.kegg.jp/kegg.
[14]	SZKLARCZYK D, GABLE A L, LYON D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets[J]. Nucleic acids research, 2019, 47(D1):D607-D613. DOI: 10.1093/nar/gky1131. doi: 10.1093/nar/gky1131
[15]	JASSAL B, MATTHEWS L, VITERI G, et al. Thereactome pathway knowledge base[J]. Nucleic Acids Research, 2020, 48(D1):D498-D503. DOI: 10.1093/nar/gkz1031. doi: 10.1093/nar/gkz1031
[16]	The R Foundation. The R project for statistical computing [EB/OL].[2021-01-23]. https://www.r-project.org.
[17]	ARENDS J, BACHMANN P, BARACOS V, et al. ESPEN guidelines on nutrition in cancer patients[J]. Clinical Nutrition (Edinburgh, Scotland), 2017, 36(1):11-48. DOI: 10.1016/j.clnu.2016.07.015. doi: 10.1016/j.clnu.2016.07.015
[18]	PALMISANO M, CAPUTI F F, MERCATELLI D, et al. Dynorphinergic system alterations in the corticostriatal circuitry of neuropathic mice support its role in the negative affective component of pain[J]. Genes, Brain, and Behavior, 2019, 18(6):e12467. DOI: 10.1111/gbb.12467. doi: 10.1111/gbb.12467
[19]	LALANNE L, AYRANCI G, KIEFFER B L, et al. The kappa opioid receptor: From addiction to depression, and back[J]. Frontiers in Psychiatry, 2014, 5:170. DOI: 10.3389/fpsyt.2014.00170. doi: 10.3389/fpsyt.2014.00170
[20]	McLAUGHLIN J P, LI S, VALDEZ J, et al. Social defeat stress-induced behavioral responses are mediated by the endogenous kappa opioid system[J]. Neuropsychopharmacology, 2006, 31(6):1241-1248. DOI: 10.1038/sj.npp.1300872. doi: 10.1038/sj.npp.1300872
[21]	CARLEZON W A, BÉGUIN C, DINIERI A, et al. Depressive-like effects of the κ-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats[J]. Journal of Pharmacology and Experimental Therapeutics, 2006, 316(1):440-447. DOI: 10.1124/jpet.105.092304. doi: 10.1124/jpet.105.092304
[22]	MCLAUGHLIN J P, LAND B B, LI S, et al. Prior activation of kappa opioid receptors by U50, 488 mimics repeated forced swim stress to potentiate cocaine place preference conditioning[J]. Neuropsychopharmacology, 2006, 31(4):787-794. DOI: 10.1038/sj.npp.1300860. doi: 10.1038/sj.npp.1300860
[23]	WANG Y M. Methylation of glucocorticoid receptor gene NR3C1 and clock gene mediate the insomnia?[C]// The 2nd Youth Academic Forum of China Sleep Research Association and the compilation of the 4th Sleep Medicine Academic Conference of Sichuan Medical Association. Chengdu: Sichuan Medical Association, Chinese Sleep Research Association, 2015.
[24]	QING L L, LIU L L, ZHOU L, et al. Sex-dependent association of mineralocorticoid receptor gene (NR3C2) DNA methylation and schizophrenia[J]. Psychiatry Research, 2020, 292:113318. DOI: 10.1016/j.psychres.2020.113318. doi: 10.1016/j.psychres.2020.113318
[25]	STARR L R, HUANG M. HPA-axismultilocus genetic variation moderates associations between environmental stress and depressive symptoms among adolescents[J]. Development and Psychopathology, 2019, 31(4):1339-1352. DOI: 10.1017/S0954579418000779. doi: 10.1017/S0954579418000779
[26]	岑昕贝, 凌济忠, 万跃平, 等. NR3C1 表达与前列腺癌生化复发的相关性研究[J]. 广州医药, 2020, 51(4):22-27. DOI: 10.3969/j.issn.1000-8535.2020.04.005. doi: 10.3969/j.issn.1000-8535.2020.04.005
[27]	IFTIMOVICI A, KEBIR O, HE Q, et al. Stress, cortisol and NR3C1 in at-risk individuals for psychosis: A Mendelian randomization study[J]. Frontiers in Psychiatry, 2020, 11:680. DOI: 10.3389/fpsyt.2020.00680. doi: 10.3389/fpsyt.2020.00680
[28]	LIND G E, KLEIVi K, MELING G I, et al. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis[J]. Analytical Cellular Pathology, 2006, 28(5/6):259-272. DOI: 10.1155/2006/949506. doi: 10.1155/2006/949506
[29]	ZHAO X L, SHEN F Z, MA J W, et al. CREB1-induced miR-1204 promoted malignant phenotype of glioblastoma through targeting NR3C2[J]. Cancer Cell International, 2020, 20:111. DOI: 10.1186/s12935-020-01176-0. doi: 10.1186/s12935-020-01176-0
[30]	GUO J Y, WANG Y K, LÜ B, et al. miR-454 performs tumor-promoting effects in oral squamous cell carcinoma via reducing NR3C2[J]. Journal of Oral Pathology & Medicine, 2020, 49(4):286-293. DOI: 10.1111/jop.13015. doi: 10.1111/jop.13015
[31]	YU M, YU H L, LI Q H, et al. miR-4709 overexpression facilitates cancer proliferation and invasion via downregulating NR3C2 and is an unfavorable prognosis factor in colon adenocarcinoma[J]. Journal of Biochemical and Molecular Toxicology, 2019, 33(12):e22411. DOI: 10.1002/jbt.22411. doi: 10.1002/jbt.22411
[32]	LIN X, WANG Z Y, XUE G, et al. ADORA1 is a diagnostic-related biomarker and correlated with immune infiltrates in papillary thyroid carcinoma[J]. Journal of Cancer, 2021, 12(13):3997-4010. DOI: 10.7150/jca.50743. doi: 10.7150/jca.50743
[33]	LIU H, KUANG X W, ZHANG Y C, et al. ADORA1 inhibition promotes tumor immune evasion by regulating the ATF3-PD-L1 axis[J]. Cancer Cell, 2020, 37(3): 324-339.e8. DOI: 10.1016/j.ccell.2020.02.006. doi: 10.1016/j.ccell.2020.02.006
[34]	HERBET M, NATORSKA-CHOMICKA D, OSTROWSKA M, et al. Edaravone presents antidepressant-like activity in corticosterone model of depression in mice with possible role of Fkbp5, Comt, Adora1 and Slc6a15 genes[J]. Toxicology and applied pharmacology, 2019, 380:114689. DOI: 10.1016/j.taap.2019.114689. doi: 10.1016/j.taap.2019.114689
[35]	SZOPA A, POLESZAK E, DOBOSZEWSKA U, et al. Withdrawal of caffeine after its chronic administration modifies the antidepressant-like activity of atypical antidepressants in mice. Changes in cortical expression ofComt, Slc6a15 and Adora1 genes[J]. Psychopharmacology, 2018, 235(8):2423-2434. DOI: 10.1007/s00213-018-4940-6. doi: 10.1007/s00213-018-4940-6

Metrics

Comments

Recommended 0

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits third parties to freely share (i.e., copy and redistribute the material in any medium or format) and adapt (i.e., remix, transform, or build upon the material) the articles published in this journal, provided that appropriate credit is given, a link to the license is provided, and any changes made are indicated. The material may not be used for commercial purposes. For details of the CC BY-NC 4.0 license, please visit: https://creativecommons.org/licenses/by-nc/4.0

Mechanism of Fuzheng Tiaoli Decoction based on network pharmacology and its effect on S180 tumor-bearing mice

RichHTML

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 9

References 35

Related Articles 15

Metrics

Comments

Recommended 0

[1]	GUO Yingjian, YU Jinqian, DONG Hongjing, WANG Chuangchuang, ZHONG Kai, WANG Xiao. Topological analysis reveals mechanism of Panax notoginseng saponin in the treatment of gouty arthritis based on network pharmacology and in vitro experiments [J]. Shandong Science, 2025, 38(5): 40-48.
[2]	SUN Jingtian, LIU Feng, ZHANG Zhe, ZHANG Yufu, MA Xinhui, LI Qingjun, WANG Xiao, DONG Hongjing. Exploring the medication rule of Chrysanthemum morifolium Ramat. and investigating the synergistic pharmacological activity of core combination herbs [J]. Shandong Science, 2025, 38(1): 1-8.
[3]	HAN Huijie, LIU Hui, ZHAO Yongbo, WANG Songpo. A study based on network pharmacology and experimental verification exploring the mechanism of quercetin against colorectal cancer through the p53 signaling pathway [J]. Shandong Science, 2025, 38(1): 32-43.
[4]	FAN Wei, SHEN Chuanlin, ZHANG Xuanming, DU Xingshuo, ZHAN Wen, SUN Chen, JIN Meng, LI Xiaobin, ZHANG Sichen, SUN Botong, HE Qiuxia. Prediction of anti-aging mechanism of Panax quinquefolius L. by network pharmacology and molecular docking [J]. Shandong Science, 2024, 37(6): 42-50.
[5]	YAN Jin, LI Fei, WU Keming, YANG Haobo. The molecular mechanisms by which Xinjia Cistanche Tusi Decoction promotes follicular development through mitophagy [J]. Shandong Science, 2024, 37(5): 25-34.
[6]	LIN Shenghua, XUE Chang, MA honglin, FAN Wei, SHEN Chuanlin, CHEN Jiayu, SUN Botong, DU Xingshuo, ZHAN Wen, LI Xiaobin, ZHANG Shanshan, JIN Meng, HE Qiuxia. Study of the active components and mechanism of action of antithrombotic Xuefuzhuyu oral liquid based on network pharmacology and molecular docking technology [J]. Shandong Science, 2024, 37(4): 26-33.
[7]	MA Shijing, HE Chunyan, GUAN Tianzhu, YAO Xueshuang, ZHANG Junpeng. Exploration of antihyperlipidemia mechanism of Monopterus albus peptides based on hyperlipidemic zebrafish model and network pharmacology [J]. Shandong Science, 2024, 37(3): 27-38.
[8]	WEI Zekun, YANG Yujie, LIU Shuang, WANG Yan, DONG Hongjing, LIU Chunmei. Reverse mining of Chinese medicine for intervention of liver cancer based on GEO database combined with network pharmacology and molecular docking technology [J]. Shandong Science, 2024, 37(3): 39-47.
[9]	LIU Kechun, WANG Yongcheng, ZANG Xiaohan, XIA Qing, ZHANG Yun, ZHANG Shanshan, SUN Chen. Advancements in network pharmacology and zebrafish modeling for studying traditional Chinese medicine’s effective substances and mechanisms of action [J]. Shandong Science, 2024, 37(2): 29-35.
[10]	FU Zhaoju, CHENG Guo, LIN Dengmei, LI Jun, ZHANG Nannan. Experimental study and network pharmacological analysis of the anti-inflammatory action mechanism of Mahonia bealei (Fort.) Carr. [J]. Shandong Science, 2024, 37(1): 24-31.
[11]	CHEN Chun, QI Daqing, PAN Jingwen. Clinical significance of stromal cell score in gastric cancer and intervention with Weifuchun capsules [J]. Shandong Science, 2023, 36(6): 38-47.
[12]	MU Nana, LIAO Binbin, LI Zhen, LI Jipin, LI Yihua, WANG Ying, CHEN Xubing. Investigating the mechanism of action of Elephantopus scaber L. in the treatment of ulcerative colitis based on network pharmacology and molecular docking [J]. Shandong Science, 2023, 36(6): 48-55.
[13]	WANG Yifan, ZHANG Zhe, TIAN Caijun. Mechanism of Sanhuang Xiexin decoction in treatment of Alzheimer's disease based on network pharmacology and molecular docking method [J]. Shandong Science, 2023, 36(5): 19-26.
[14]	FU Mengya, AO Huihao, BU Chao, PENG Tangyi, WU Deling, HAN Yanquan, HONG Yan. Forecast analysis of the quality markers of Zingiberis Rhizoma based on fingerprints and network pharmacology [J]. Shandong Science, 2023, 36(4): 35-41.
[15]	YIN Zhipeng, GAO Yunyun, LIU Wenwen, GUO Pengbo, ZHAO Yinghui. Exploring the mechanism of Xiangsha Liujunzi Decoction in treating Helicobacter pylori-associated gastritis based on network pharmacology and molecular docking technology [J]. Shandong Science, 2023, 36(4): 52-60.